{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Panax ginseng", "Paullinia cupana", "antioxidant activity", "ayurvedic", "brain injury", "learning", "memory", "nootropics", "piracetam", "smart drugs"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36014874", "DateCompleted": {"Year": "2022", "Month": "08", "Day": "29"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "17"}], "Language": ["eng"], "ELocationID": ["3367", "10.3390/nu14163367"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "14", "Issue": "16", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "17"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.", "Abstract": {"AbstractText": ["Nootropics, also known as \"smart drugs\" are a diverse group of medicinal substances whose action improves human thinking, learning, and memory, especially in cases where these functions are impaired. This review provides an up-to-date overview of the potential effectiveness and importance of nootropics. Based on their nature and their effects, this heterogeneous group of drugs has been divided into four subgroups: classical nootropic compounds, substances increasing brain metabolism, cholinergic, and plants and their extracts with nootropic effects. Each subgroup of nootropics contains several main representatives, and for each one, its uses, indications, experimental treatments, dosage, and possible side effects and contraindications are discussed. For the nootropic plant extracts, there is also a brief description of each plant representative, its occurrence, history, and chemical composition of the medicinal part. Lastly, specific recommendations regarding the use of nootropics by both ill and healthy individuals are summarized."]}, "AuthorList": [{"Identifier": ["0000-0002-2717-3740"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agroenvironmental Chemistry and Plant Nutrition, Czech University of Life Sciences Prague, Kam\u00fdck\u00e1 129, 165 00 Prague, Czech Republic."}], "LastName": "Mal\u00edk", "ForeName": "Mat\u011bj", "Initials": "M"}, {"Identifier": ["0000-0003-1274-0658"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agroenvironmental Chemistry and Plant Nutrition, Czech University of Life Sciences Prague, Kam\u00fdck\u00e1 129, 165 00 Prague, Czech Republic."}], "LastName": "Tlusto\u0161", "ForeName": "Pavel", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Nootropic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Drug-Related Side Effects and Adverse Reactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Learning"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Nootropic Agents"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Giurgea C., Salama M. Nootropic drugs. Prog. Neuro-Psychopharmacol. 1977;1:235\u2013247. doi: 10.1016/0364-7722(77)90046-7.", "ArticleIdList": ["10.1016/0364-7722(77)90046-7"]}, {"Citation": "Schifano F., Catalani V., Sharif S., Napoletano F., Corkery J.M., Arillotta D., Fergus S., Vento A., Guirguis A. Benefits and Harms of \u2018Smart Drugs\u2019 (Nootropics) in Healthy Individuals. Drugs. 2022;82:633\u2013647. doi: 10.1007/s40265-022-01701-7.", "ArticleIdList": ["10.1007/s40265-022-01701-7", "35366192"]}, {"Citation": "Vyas S., Kothari S., Kachhwaha S. Nootropic medicinal plants: Therapeutic alternatives for Alzheimer\u2019s disease. J. Herb. Med. 2019;17:100291. doi: 10.1016/j.hermed.2019.100291.", "ArticleIdList": ["10.1016/j.hermed.2019.100291"]}, {"Citation": "Ihl R., Kretschmar C. Nootropic drug evaluation for general practice. Nervenarzt. 1997;68:853\u2013861. doi: 10.1007/s001150050207.", "ArticleIdList": ["10.1007/s001150050207", "9732727"]}, {"Citation": "Chaudhari K.S., Tiwari N.R., Tiwari R.R., Sharma R.S. Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer\u2019s Disease. Ann. Neurosci. 2017;24:111\u2013122. doi: 10.1159/000475900.", "ArticleIdList": ["10.1159/000475900", "PMC5448442", "28588366"]}, {"Citation": "Benninghoff J., Perneczky R. Anti-Dementia Medications and Anti-Alzheimer\u2019s Disease Drugs: Side Effects, Contraindications, and Interactions. In: Riederer P., Laux G., Nagatsu T., Le W., Riederer C., editors. NeuroPsychopharmacotherapy. Springer International Publishing; Cham, Switzerland: 2022. pp. 1\u201310.", "ArticleIdList": ["10.1007/978-3-319-56015-1_195-1"]}, {"Citation": "Dormehl I.C., Jordaan B., Oliver D.W., Croft S. SPECT monitoring of improved cerebral blood flow during long-term treatment of elderly patients with nootropic drugs. Clin. Nucl. Med. 1999;24:29\u201334. doi: 10.1097/00003072-199901000-00007.", "ArticleIdList": ["10.1097/00003072-199901000-00007", "9890490"]}, {"Citation": "Napoletano F., Schifano F., Corkery J.M., Guirguis A., Arillotta D., Zangani C., Vento A. The Psychonauts\u2019 World of Cognitive Enhancers. Front. Psychiatry. 2020;11:546796. doi: 10.3389/fpsyt.2020.546796.", "ArticleIdList": ["10.3389/fpsyt.2020.546796", "PMC7516264", "33024436"]}, {"Citation": "Malik R., Sangwan A., Saihgal R., Paul Jindal D., Piplani P. Towards better brain management: Nootropics. Curr. Med. Chem. 2007;14:123\u2013131. doi: 10.2174/092986707779313408.", "ArticleIdList": ["10.2174/092986707779313408", "17266573"]}, {"Citation": "Giurgea C. The \u201cnootropic\u201d approach to the pharmacology of the integrative activity of the brain 1, 2. Integr. Psychol. Behav. Sci. 1973;8:108\u2013115. doi: 10.1007/BF03000311.", "ArticleIdList": ["10.1007/BF03000311", "4736348"]}, {"Citation": "Giurgea C. Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology. Actual. Pharm. 1972;25:115\u2013156.", "ArticleIdList": ["4541214"]}, {"Citation": "Zhao X., Yeh J.Z., Narahashi T. Post-Stroke Dementia: Nootropic Drug Modulation of Neuronal Nicotinic Acetylcholine Receptors. Ann. N. Y. Acad. Sci. 2001;939:179\u2013186. doi: 10.1111/j.1749-6632.2001.tb03624.x.", "ArticleIdList": ["10.1111/j.1749-6632.2001.tb03624.x", "11462769"]}, {"Citation": "Zhao X., Kuryatov A., Lindstrom J.M., Yeh J.Z., Narahashi T. Nootropic Drug Modulation of Neuronal Nicotinic Acetylcholine Receptors in Rat Cortical Neurons. Mol. Pharmacol. 2001;59:674\u2013683. doi: 10.1124/mol.59.4.674.", "ArticleIdList": ["10.1124/mol.59.4.674", "11259610"]}, {"Citation": "Suliman N.A., Mat Taib C.N., Mohd Moklas M.A., Adenan M.I., Hidayat Baharuldin M.T., Basir R. Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evid.-Based Complement. Altern. Med. 2016;2016:4391375. doi: 10.1155/2016/4391375.", "ArticleIdList": ["10.1155/2016/4391375", "PMC5021479", "27656235"]}, {"Citation": "Froestl W., Muhs A., Pfeifer A. Cognitive enhancers (nootropics). Part 1: Drugs interacting with receptors. J. Alzheimer\u2019s Dis. 2012;32:793\u2013887. doi: 10.3233/JAD-2012-121186.", "ArticleIdList": ["10.3233/JAD-2012-121186", "22886028"]}, {"Citation": "Mali A., Shenoy P., Bandawane D., Nipate S., Chaudhari P. Screening of nootropics: An overview on preclinical evaluation techniques. Int. J. Pharm. 2012;2:159\u2013180."}, {"Citation": "Joshi Pranav C. A review on natural memory enhancers (Nootropics) Unique J. Eng. Adv. Sci. 2013;1:8\u201318."}, {"Citation": "Chekman I., Belenichev I., Demchenko A., Bobrova V., Kucherenko L., Gorchakova N., Bukhtiyarova N. Nootropics in comlex therapy of chronic cerebral ischemia. Sci. Innov. 2014;10:56\u201368. doi: 10.15407/scine10.04.056.", "ArticleIdList": ["10.15407/scine10.04.056"]}, {"Citation": "McDaniel M.A., Maier S.F., Einstein G.O. \u201cBrain-specific\u201d nutrients: A memory cure? Nutrition. 2003;19:957\u2013975. doi: 10.1016/S0899-9007(03)00024-8.", "ArticleIdList": ["10.1016/S0899-9007(03)00024-8", "14624946"]}, {"Citation": "Ishchenko M.M., Ostrovskaia O.S. The effect of combined drug treatment on rheologic properties of the blood in patients with disordered circulatory encephalopathy. Vrachebnoe Delo. 1990;3:58\u201360.", "ArticleIdList": ["2368364"]}, {"Citation": "Nicholson C.D. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology. 1990;101:147\u2013159. doi: 10.1007/BF02244119.", "ArticleIdList": ["10.1007/BF02244119", "2190256"]}, {"Citation": "Pepeu G., Spignoli G. Nootropic drugs and brain cholinergic mechanisms. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1989;13:S77\u2013S88. doi: 10.1016/0278-5846(89)90112-7.", "ArticleIdList": ["10.1016/0278-5846(89)90112-7", "2694231"]}, {"Citation": "Rainer M., Mucke H.A., Chwatal K., Havelec L. Alcohol-induced organic cerebral psychosyndromes: Partial reversal of cognitive impairments assisted by dihydroergocristine. Psychopharmacology. 1996;127:365\u2013369. doi: 10.1007/BF02806016.", "ArticleIdList": ["10.1007/BF02806016", "8923573"]}, {"Citation": "Bene\u0161ov\u00e1 O. Neuropathobiology of senile dementia and mechanism of action of nootropic drugs. Drugs Aging. 1994;4:285\u2013303. doi: 10.2165/00002512-199404040-00002.", "ArticleIdList": ["10.2165/00002512-199404040-00002", "8019052"]}, {"Citation": "Wu C.-Y., Hu H.-Y., Chow L.-H., Chou Y.-J., Huang N., Wang P.-N., Li C.-P. The effects of anti-dementia and nootropic treatments on the mortality of patients with dementia: A population-based cohort study in Taiwan. PLoS ONE. 2015;10:e0130993. doi: 10.1371/journal.pone.0130993.", "ArticleIdList": ["10.1371/journal.pone.0130993", "PMC4476616", "26098910"]}, {"Citation": "Finney-Brown T. Schisandra, Rhodiola and Eleuthrococcus as nootropic agents. Aust. J. Herb. Med. 2010;22:64\u201365."}, {"Citation": "Panossian A., Wikman G. Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress\u2014Protective Activity. Pharmaceuticals. 2010;3:188\u2013224. doi: 10.3390/ph3010188.", "ArticleIdList": ["10.3390/ph3010188", "PMC3991026", "27713248"]}, {"Citation": "Zavadenko N., NIu S., Rumiantseva M., Ovchinnikova A. The use of instenon in children with minimal brain dysfunction. Zhurnal Nevrol. Psikhiatrii Im. SS Korsakova. 2002;102:29\u201335.", "ArticleIdList": ["12087730"]}, {"Citation": "Colucci L., Bosco M., Ziello A.R., Rea R., Amenta F., Fasanaro A.M. Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: A review. J. Exp. Pharmacol. 2012;4:163\u2013172. doi: 10.2147/JEP.S35326.", "ArticleIdList": ["10.2147/JEP.S35326", "PMC4863555", "27186129"]}, {"Citation": "Zokiriv M. Correction of cognitive impairments in patients with HIV-associated encephalopathy. J. Theor. Appl. Sci. 2021;7:62\u201366. doi: 10.15863/TAS.2021.07.99.15.", "ArticleIdList": ["10.15863/TAS.2021.07.99.15"]}, {"Citation": "Kupats E., Vrublevska J., Zvejniece B., Vavers E., Stelfa G., Zvejniece L., Dambrova M. Safety and tolerability of the anxiolytic and nootropic drug phenibut: A systematic review of clinical trials and case reports. Pharmacopsychiatry. 2020;53:201\u2013208. doi: 10.1055/a-1151-5017.", "ArticleIdList": ["10.1055/a-1151-5017", "32340063"]}, {"Citation": "Voronina T.A. Alzheimer Disease. Springer; Berlin/Heidelberg, Germany: 1994. Nootropic drugs in Alzheimer disease treatment. New pharmacological strategies; pp. 265\u2013269."}, {"Citation": "Noorbala A., Akhondzadeh S., Davari-Ashtiani R., Amini-Nooshabadi H. Piracetam in the treatment of schizophrenia: Implications for the glutamate hypothesis of schizophrenia. J. Clin. Pharm. Ther. 1999;24:369\u2013374. doi: 10.1046/j.1365-2710.1999.00238.x.", "ArticleIdList": ["10.1046/j.1365-2710.1999.00238.x", "10583700"]}, {"Citation": "Sukhotina N., Konovalova V., Kryzhanovskaia I., Kupriianova T. Efficacy of pantogam in the treatment of hyperkinetic disorders in children. Zhurnal Nevrol. Psikhiatrii Im. SS Korsakova. 2010;110:24\u201328.", "ArticleIdList": ["21311483"]}, {"Citation": "Sarris J., Kean J., Schweitzer I., Lake J. Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): A systematic review of the evidence. Complement. Ther. Med. 2011;19:216\u2013227. doi: 10.1016/j.ctim.2011.06.007.", "ArticleIdList": ["10.1016/j.ctim.2011.06.007", "21827936"]}, {"Citation": "Teasdale G., Jennett B. Assessment of Coma and Impaired Consciousness: A Practical Scale. Lancet. 1974;304:81\u201384. doi: 10.1016/S0140-6736(74)91639-0.", "ArticleIdList": ["10.1016/S0140-6736(74)91639-0", "4136544"]}, {"Citation": "Canterbury R.J., Lloyd E. Smart drugs: Implications of student use. J. Prim. Prev. 1994;14:197\u2013207. doi: 10.1007/BF01324593.", "ArticleIdList": ["10.1007/BF01324593", "24258820"]}, {"Citation": "Wagner H., Ulrich-Merzenich G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97\u2013110. doi: 10.1016/j.phymed.2008.12.018.", "ArticleIdList": ["10.1016/j.phymed.2008.12.018", "19211237"]}, {"Citation": "Caesar L.K., Cech N.B. Synergy and antagonism in natural product extracts: When 1 + 1 does not equal 2. Nat. Prod. Rep. 2019;36:869\u2013888. doi: 10.1039/C9NP00011A.", "ArticleIdList": ["10.1039/C9NP00011A", "PMC6820002", "31187844"]}, {"Citation": "Balunas M.J., Kinghorn A.D. Drug discovery from medicinal plants. Life Sci. 2005;78:431\u2013441. doi: 10.1016/j.lfs.2005.09.012.", "ArticleIdList": ["10.1016/j.lfs.2005.09.012", "16198377"]}, {"Citation": "Petrovska B.B. Historical review of medicinal plants\u2019 usage. Pharmacogn. Rev. 2012;6:1\u20135. doi: 10.4103/0973-7847.95849.", "ArticleIdList": ["10.4103/0973-7847.95849", "PMC3358962", "22654398"]}, {"Citation": "Malykh A.G., Sadaie M.R. Piracetam and Piracetam-Like Drugs. Drugs. 2010;70:287\u2013312. doi: 10.2165/11319230-000000000-00000.", "ArticleIdList": ["10.2165/11319230-000000000-00000", "20166767"]}, {"Citation": "Chary M., Yi D., Manini A.F. Candyflipping and Other Combinations: Identifying Drug\u2013Drug Combinations from an Online Forum. Front. Psychiatry. 2018;9:135. doi: 10.3389/fpsyt.2018.00135.", "ArticleIdList": ["10.3389/fpsyt.2018.00135", "PMC5936764", "29760666"]}, {"Citation": "Elks J. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer; Berlin/Heidelberg, Germany: 2014."}, {"Citation": "Malanga G., Aguiar M.B., Martinez H.D., Puntarulo S. New insights on dimethylaminoethanol (DMAE) features as a free radical scavenger. Drug Metab. Lett. 2012;6:54\u201359. doi: 10.2174/187231212800229282.", "ArticleIdList": ["10.2174/187231212800229282", "22300295"]}, {"Citation": "Blin O., Audebert C., Pitel S., Kaladjian A., Casse-Perrot C., Zaim M., Micallef J., Tisne-Versailles J., Sokoloff P., Chopin P., et al. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: Evidence from preclinical and clinical studies. Psychopharmacology. 2009;207:201\u2013212. doi: 10.1007/s00213-009-1648-7.", "ArticleIdList": ["10.1007/s00213-009-1648-7", "19756528"]}, {"Citation": "Levin E.D., Rose J.E., Abood L. Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacol. Biochem. Behav. 1995;51:369\u2013373. doi: 10.1016/0091-3057(94)00406-9.", "ArticleIdList": ["10.1016/0091-3057(94)00406-9", "7667355"]}, {"Citation": "Dimpfel W., Wedekind W., Keplinger I. Efficacy of dimethylaminoethanol (DMAE) containing vitamin-mineral drug combination on EEG patterns in the presence of different emotional states. Eur. J. Med. Res. 2003;8:183\u2013191.", "ArticleIdList": ["12844472"]}, {"Citation": "Sergio W. Use of DMAE (2-dimethylaminoethanol) in the induction of lucid dreams. Med. Hypotheses. 1988;26:255\u2013257. doi: 10.1016/0306-9877(88)90129-6.", "ArticleIdList": ["10.1016/0306-9877(88)90129-6", "3173167"]}, {"Citation": "Baumgaertel A. Alternative and Controversial Treatments for Attention-Deficit/Hyperactivity Disorder. Pediatr. Clin. N. Am. 1999;46:977\u2013992. doi: 10.1016/S0031-3955(05)70167-X.", "ArticleIdList": ["10.1016/S0031-3955(05)70167-X", "10570700"]}, {"Citation": "Lewis J.A., Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin. Pharm. Therap. 1975;17:534\u2013540. doi: 10.1002/cpt1975175534.", "ArticleIdList": ["10.1002/cpt1975175534", "1092513"]}, {"Citation": "Casey D.E. Mood alterations during deanol therapy. Psychopharmacology. 1979;62:187\u2013191. doi: 10.1007/BF00427135.", "ArticleIdList": ["10.1007/BF00427135", "111283"]}, {"Citation": "Ferris S.H., Sathananthan G., Gershon S., Clark C. Senile Dementia: Treatment with Deanol. J. Am. Geriatr. Soc. 1977;25:241\u2013244. doi: 10.1111/j.1532-5415.1977.tb00407.x.", "ArticleIdList": ["10.1111/j.1532-5415.1977.tb00407.x", "864168"]}, {"Citation": "Wood P.L., P\u00e9loquin A. Increases in choline levels in rat brain elicited by meclofenoxate. Neuropharmacology. 1982;21:349\u2013354. doi: 10.1016/0028-3908(82)90099-5.", "ArticleIdList": ["10.1016/0028-3908(82)90099-5", "6806676"]}, {"Citation": "Liao Y., Wang R., Tang X.-C. Centrophenoxine improves chronic cerebral ischemia induced cognitive deficit and neuronal degeneration in rats. Acta Pharmacol. Sin. 2004;25:1590\u20131596.", "ArticleIdList": ["15569402"]}, {"Citation": "Bakhtogarimov I.R., Kudryavtseva A.V., Krasnov G.S., Gladysh N.S., Volodin V.V., Kudryavtsev A.A., Bulavkina E.V., Goncharova M.A., Ledyaeva V.S., Pastukhov I.S., et al. The Effect of Meclofenoxate on the Transcriptome of Aging Brain of Nothobranchius guentheri Annual Killifish. Int. J. Mol. Sci. 2022;23:2491. doi: 10.3390/ijms23052491.", "ArticleIdList": ["10.3390/ijms23052491", "PMC8910246", "35269638"]}, {"Citation": "Marcer D., Hopkins S.M. The Differential Effects of Meclofenoxate on Memory Loss in the Elderly. Age Ageing. 1977;6:123\u2013131. doi: 10.1093/ageing/6.2.123.", "ArticleIdList": ["10.1093/ageing/6.2.123", "329662"]}, {"Citation": "Izumi K., Tominaga H., Koja T., Nomoto M., Shimizu T., Sonoda H., Imamura K., Igata A., Fukuda T. Meclofenoxate therapy in tardive dyskinesia: A preliminary report. Biol. Psychiatry. 1986;21:151\u2013160. doi: 10.1016/0006-3223(86)90142-3.", "ArticleIdList": ["10.1016/0006-3223(86)90142-3", "2868761"]}, {"Citation": "Popa R., Schneider F., Mihalas G., Stefaniga P., Mihalas I.G., Maties R., Mateescu R. Antagonic-stress superiority versus meclofenoxate in gerontopsychiatry (alzheimer type dementia) Arch. Gerontol. Geriatr. 1994;19:197\u2013206. doi: 10.1016/S0167-4943(05)80065-2.", "ArticleIdList": ["10.1016/S0167-4943(05)80065-2", "18649860"]}, {"Citation": "Oliver J.E., Restell M. Serial Testing in Assessing the Effect of Meclofenoxate on Patients with Memory Defects. Br. J. Psychiatry. 1967;113:219\u2013222. doi: 10.1192/bjp.113.495.219.", "ArticleIdList": ["10.1192/bjp.113.495.219", "4382246"]}, {"Citation": "Winblad B., Fioravanti M., Dolezal T., Logina I., Milanov I.G., Popescu D.C., Solomon A. Therapeutic Use of Nicergoline. Clin. Drug Investig. 2008;28:533\u2013552. doi: 10.2165/00044011-200828090-00001.", "ArticleIdList": ["10.2165/00044011-200828090-00001", "18666801"]}, {"Citation": "Winblad B., Carfagna N., Bonura L., Rossini B.M., Wong E.H.F., Battaglia A. Nicergoline in Dementia. CNS Drugs. 2000;14:267\u2013287. doi: 10.2165/00023210-200014040-00003.", "ArticleIdList": ["10.2165/00023210-200014040-00003"]}, {"Citation": "Caraci F., Chisari M., Frasca G., Canonico P.L., Battaglia A., Calafiore M., Battaglia G., Bosco P., Nicoletti F., Copani A., et al. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against \u03b2-amyloid toxicity. Brain Res. 2005;1047:30\u201337. doi: 10.1016/j.brainres.2005.04.004.", "ArticleIdList": ["10.1016/j.brainres.2005.04.004", "15882840"]}, {"Citation": "Giardino L., Giuliani A., Battaglia A., Carfagna N., Aloe L., Calz\u00e0 L. Neuroprotection and aging of the cholinergic system: A role for the ergoline derivative nicergoline (Sermion\u00ae) Neuroscience. 2002;109:487\u2013497. doi: 10.1016/S0306-4522(01)00470-5.", "ArticleIdList": ["10.1016/S0306-4522(01)00470-5", "11823061"]}, {"Citation": "Heitz C., Descombes J.-J., Miller R.C., Stoclet J.-C. \u03b1-adrenoceptor antagonistic and calcium antagonistic effects of nicergoline in the rat isolated aorta. Eur. J. Pharmacol. 1986;123:279\u2013285. doi: 10.1016/0014-2999(86)90669-2.", "ArticleIdList": ["10.1016/0014-2999(86)90669-2", "3011463"]}, {"Citation": "Molteni A., Nickerson P.A., Brownie A.C., Liu K. Effect on an ergoline derivate-nicergoline (Sermion) on methylandrostenediol-induced hypertension in the rat. Arch. Int. Pharmacodyn. Ther. 1980;247:119\u2013134.", "ArticleIdList": ["7447555"]}, {"Citation": "Tanaka M., Yoshida T., Okamoto K., Hirai S. Antioxidant properties of nicergoline; inhibition of brain auto-oxidation and superoxide production of neutrophils in rats. Neurosci. Lett. 1998;248:68\u201372. doi: 10.1016/S0304-3940(98)00310-3.", "ArticleIdList": ["10.1016/S0304-3940(98)00310-3", "9665666"]}, {"Citation": "Zang G., Fang L., Chen L., Wang C. Ameliorative effect of nicergoline on cognitive function through the PI3K/AKT signaling pathway in mouse models of Alzheimer\u2019s disease. Mol. Med. Rep. 2018;17:7293\u20137300. doi: 10.3892/mmr.2018.8786.", "ArticleIdList": ["10.3892/mmr.2018.8786", "29568940"]}, {"Citation": "Iliff L.D., Boulay G.H.D., Marshall J., Russell R.W.R., Symon L. Effect of nicergoline on cerebral blood flow. J. Neurol. Neurosurg. Psychiatry. 1977;40:746\u2013747. doi: 10.1136/jnnp.40.8.746.", "ArticleIdList": ["10.1136/jnnp.40.8.746", "PMC492828", "925694"]}, {"Citation": "Baskys A., Hou A.C. Vascular dementia: Pharmacological treatment approaches and perspectives. Clin. Interv. Aging. 2007;2:327\u2013335. doi: 10.1016/j.exger.2012.07.002.", "ArticleIdList": ["10.1016/j.exger.2012.07.002", "PMC2685259", "18044183"]}, {"Citation": "Kuznetsov V. The influence of nicergoline on cerebral, systemic and cardiac hemodynamics in patients who have had an ischemic stroke. Ageing Long. 2021;2:32\u201341. doi: 10.47855/jal9020-2021-1-3.", "ArticleIdList": ["10.47855/jal9020-2021-1-3"]}, {"Citation": "Saletu B., Paulus E., Linzmayer L., Anderer P., Semlitsch H.V., Gr\u00fcnberger J., Wicke L., Neuhold A., Podreka I. Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: A double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology. 1995;117:385\u2013395. doi: 10.1007/BF02246209.", "ArticleIdList": ["10.1007/BF02246209", "7604138"]}, {"Citation": "Fioravanti M., Nakashima T., Xu J., Garg A. A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline. BMJ Open. 2014;4:e005090. doi: 10.1136/bmjopen-2014-005090.", "ArticleIdList": ["10.1136/bmjopen-2014-005090", "PMC4120366", "25079927"]}, {"Citation": "Klamkam P., Pagcharoenpol R., Treesaranuwattana T., Silpsrikul P., Jaruchinda P., Wasuwat P., Suwannahitatorn P. A clinical trial of nicergoline to prevent temporary threshold shift. Laryngoscope Investig. Otolaryngol. 2022;7:515\u2013522. doi: 10.1002/lio2.746.", "ArticleIdList": ["10.1002/lio2.746", "PMC9008157", "35434325"]}, {"Citation": "Gouliaev A.H., Senning A. Piracetam and other structurally related nootropics. Brain Res. Rev. 1994;19:180\u2013222. doi: 10.1016/0165-0173(94)90011-6.", "ArticleIdList": ["10.1016/0165-0173(94)90011-6", "8061686"]}, {"Citation": "Stoll L., Schubert T., M\u00fcller W.E. Age-related deficits of central muscarinic cholinergic receptor function in the mouse: Partial restoration by chronic piracetam treatment. Neurobiol. Aging. 1992;13:39\u201344. doi: 10.1016/0197-4580(92)90006-J.", "ArticleIdList": ["10.1016/0197-4580(92)90006-J", "1542379"]}, {"Citation": "Scheuer K., Rostock A., Bartsch R., M\u00fcller W. Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain. Pharmacopsychiatry. 1999;32:10\u201316. doi: 10.1055/s-2007-979231.", "ArticleIdList": ["10.1055/s-2007-979231", "10338103"]}, {"Citation": "Nickolson V.J., Wolthuis O.L. Effect of the acquisition-enhancing drug ptracetam on rat cerebral energy metabolism. Comparison with naftidrofuryl and methamphetamine. Biochem. Pharmacol. 1976;25:2241\u20132244. doi: 10.1016/0006-2952(76)90004-6.", "ArticleIdList": ["10.1016/0006-2952(76)90004-6", "985556"]}, {"Citation": "Tacconi M.T., Wurtman R.J. Piracetam: Physiological disposition and mechanism of action. Adv. Neurol. 1986;43:675\u2013685.", "ArticleIdList": ["3946121"]}, {"Citation": "Grau M., Montero J.L., Balasch J. Effect of piracetam on electrocorticogram and local cerebral glucose utilization in the rat. Vasc. Pharmacol. 1987;18:205\u2013211. doi: 10.1016/0306-3623(87)90252-7.", "ArticleIdList": ["10.1016/0306-3623(87)90252-7", "3569848"]}, {"Citation": "Brandao F., Paula-Barbosa M.M., Cadete-Leite A. Piracetam impedes hippocampal neuronal loss during withdrawal after chronic alcohol intake. Alcohol. 1995;12:279\u2013288. doi: 10.1016/0741-8329(94)00107-O.", "ArticleIdList": ["10.1016/0741-8329(94)00107-O", "7639963"]}, {"Citation": "Brand\u00e3o F., Cadete-Leite A., Andrade J.P., Madeira M.D., Paula-Barbosa M.M. Piracetam promotes mossy fiber synaptic reorganization in rats withdrawn from alcohol. Alcohol. 1996;13:239\u2013249. doi: 10.1016/0741-8329(95)02050-0.", "ArticleIdList": ["10.1016/0741-8329(95)02050-0", "8734838"]}, {"Citation": "Winnicka K., Tomasiak M., Bielawska A. Piracetam-an old drug with novel properties. Acta Pol. Pharm. 2005;62:405\u2013409.", "ArticleIdList": ["16459490"]}, {"Citation": "M\u00fcller W., Eckert G., Eckert A. Piracetam: Novelty in a unique mode of action. Pharmacopsychiatry. 1999;32:2\u20139. doi: 10.1055/s-2007-979230.", "ArticleIdList": ["10.1055/s-2007-979230", "10338102"]}, {"Citation": "Wilsher C.R., Bennett D., Chase C.H., Conners C.K., Diianni M., Feagans L., Hanvik L.J., Helfgott E., Koplewicz H., Overby P. Piracetam and dyslexia: Effects on reading tests. J. Clin. Psychopharmacol. 1987;7:230\u2013237. doi: 10.1097/00004714-198708000-00004.", "ArticleIdList": ["10.1097/00004714-198708000-00004", "3305591"]}, {"Citation": "Croisile B., Trillet M., Fondarai J., Laurent B., Maugui\u00e8re F., Billardon M. Long-term and high-dose piracetam treatment of Alzheimer\u2019s disease. Neurology. 1993;43:301. doi: 10.1212/WNL.43.2.301.", "ArticleIdList": ["10.1212/WNL.43.2.301", "8437693"]}, {"Citation": "Growdon J.H., Corkin S., Huff F.J., Rosen T.J. Piracetam combined with lecithin in the treatment of Alzheimer\u2019s disease. Neurobiol. Aging. 1986;7:269\u2013276. doi: 10.1016/0197-4580(86)90007-2.", "ArticleIdList": ["10.1016/0197-4580(86)90007-2", "3528889"]}, {"Citation": "Tanaka H., Yamazaki K., Hirata K. Effects of nootropic drugs for demented patients\u2014A study using LORETA. Int. Congr. Ser. 2002;1232:605\u2013611. doi: 10.1016/S0531-5131(01)00844-5.", "ArticleIdList": ["10.1016/S0531-5131(01)00844-5"]}, {"Citation": "Winblad B. Piracetam: A Review of Pharmacological Properties and Clinical Uses. CNS Drug Rev. 2005;11:169\u2013182. doi: 10.1111/j.1527-3458.2005.tb00268.x.", "ArticleIdList": ["10.1111/j.1527-3458.2005.tb00268.x", "PMC6741724", "16007238"]}, {"Citation": "Singh A., Purohit V. A critical review of pyritinol. Drugs Ther. Perspect. 2019;35:278\u2013282. doi: 10.1007/s40267-019-00623-x.", "ArticleIdList": ["10.1007/s40267-019-00623-x"]}, {"Citation": "Wojszel Z.B. Nootropics (Piracetam, Pyritinol, Co-dergocrine, Meclophenoxat, Pentoxifylline, Nimodipine) In: Riederer P., Laux G., Nagatsu T., Le W., Riederer C., editors. NeuroPsychopharmacotherapy. Springer International Publishing; Cham, Switzerland: 2020. pp. 1\u201345.", "ArticleIdList": ["10.1007/978-3-319-56015-1_419-1"]}, {"Citation": "Toledano A., Bentura M.L. Pyritinol facilitates the recovery of cortical cholinergic deficits caused by nucleus basalis lesions. J. Neural Transm. Gen. Sect. 1994;7:195\u2013209. doi: 10.1007/BF02253438.", "ArticleIdList": ["10.1007/BF02253438", "7710671"]}, {"Citation": "Martin K.J., Vyas S. Increase in acetylcholine concentrations in the brain of \u2018old\u2019 rats following treatment with pyrithioxin (Encephabol) Br. J. Pharmacol. 1987;90:561\u2013565. doi: 10.1111/j.1476-5381.1987.tb11206.x.", "ArticleIdList": ["10.1111/j.1476-5381.1987.tb11206.x", "PMC1917181", "3567461"]}, {"Citation": "Jim\u00e9nez-Andrade G.Y., Reyes-Garc\u00eda G., Sereno G., Ceballos-Reyes G., Vidal-Cant\u00fa G.C., Granados-Soto V. Pyritinol reduces nociception and oxidative stress in diabetic rats. Eur. J. Pharmacol. 2008;590:170\u2013176. doi: 10.1016/j.ejphar.2008.06.050.", "ArticleIdList": ["10.1016/j.ejphar.2008.06.050", "18593582"]}, {"Citation": "Magnusson K., Brim B., Das S. Selective vulnerabilities of N-methyl-D-aspartate (NMDA) receptors during brain aging. Front. Aging Neurosci. 2010;2:11. doi: 10.3389/fnagi.2010.00011.", "ArticleIdList": ["10.3389/fnagi.2010.00011", "PMC2874396", "20552049"]}, {"Citation": "Jaiswal A.K., Upadhyay S.N., Bhattacharya S.K. Effect of pyritinol, a cerebral protector, on learning and memory deficits induced by prenatal undernutrition and environmental impoverishment in young rats. Indian J. Exp. Biol. 1990;28:609\u2013615.", "ArticleIdList": ["2272646"]}, {"Citation": "Hindmarch I., Coleston D.M., Kerr J.S. Psychopharmacological Effects of Pyritinol in Normal Volunteers. Neuropsychobiology. 1990;24:159\u2013164. doi: 10.1159/000119478.", "ArticleIdList": ["10.1159/000119478", "2135070"]}, {"Citation": "Alkuraishy H.M., Al-Gareeb A.I., Albuhadilly A.K. Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders\u2014A Randomized Controlled Clinical Study. Biomed. Res. Int. 2014;2014:324307. doi: 10.1155/2014/324307.", "ArticleIdList": ["10.1155/2014/324307", "PMC4274818", "25548768"]}, {"Citation": "Nachbar F., Korting H.C., Vogl T. Erythema multiforme-like Eruption in Association with Severe Headache following Pyritinol. Dermatology. 1993;187:42\u201346. doi: 10.1159/000247196.", "ArticleIdList": ["10.1159/000247196", "8324277"]}, {"Citation": "Straumann A., Bauer M., Pichler W.J., Pirovino M. Acute pancreatitis due to pyritinol: An immune-mediated phenomenon. Gastroenterology. 1998;115:452\u2013454. doi: 10.1016/S0016-5085(98)70212-4.", "ArticleIdList": ["10.1016/S0016-5085(98)70212-4", "9679051"]}, {"Citation": "Leopold M. Pyritinol. In: Aronson J.K., editor. Meyler\u2019s Side Effects of Drugs. 16th ed. Elsevier; Oxford, UK: 2016. pp. 1067\u20131068.", "ArticleIdList": ["10.1016/B978-0-444-53717-1.01372-X"]}, {"Citation": "Barradell L.B., Brogden R.N. Oral Naftidrofuryl. Drugs Aging. 1996;8:299\u2013322. doi: 10.2165/00002512-199608040-00005.", "ArticleIdList": ["10.2165/00002512-199608040-00005", "8920176"]}, {"Citation": "Goldsmith D.R., Wellington K. Naftidrofuryl. Drugs Aging. 2005;22:967\u2013977. doi: 10.2165/00002512-200522110-00006.", "ArticleIdList": ["10.2165/00002512-200522110-00006", "16323973"]}, {"Citation": "Kiss B., K\u00e1rp\u00e1ti E. Mechanism of action of vinpocetine. Acta Pharm. Hung. 1996;66:213\u2013224.", "ArticleIdList": ["9082841"]}, {"Citation": "Dubey A., Kumar N., Mishra A., Singh Y., Tiwari M. Review on Vinpocetine. Int. J. Pharm. Life Sci. 2020;11:6590\u20136597."}, {"Citation": "Sharma N., Sharma V.K., Manikyam H.K., Krishna A.B. Ergot alkaloids: A review on therapeutic applications. Eur. J. Med. Plants. 2016;14:1\u201317. doi: 10.9734/EJMP/2016/25975.", "ArticleIdList": ["10.9734/EJMP/2016/25975"]}, {"Citation": "L\u00f6rincz C., Sz\u00e1sz K., Kisfaludy L. The synthesis of ethyl apovincaminate. Arzneimittelforschung. 1976;26:1907.", "ArticleIdList": ["1037211"]}, {"Citation": "Hagiwara M., Endo T., Hidaka H. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle. Biochem. Pharmacol. 1984;33:453\u2013457. doi: 10.1016/0006-2952(84)90240-5.", "ArticleIdList": ["10.1016/0006-2952(84)90240-5", "6322804"]}, {"Citation": "Moln\u00e1r P., Erd\u0151 S.L. Vinpocetine is as potent as phenytoin to block voltage-gated Na+ channels in rat cortical neurons. Eur. J. Pharmacol. 1995;273:303\u2013306. doi: 10.1016/0014-2999(94)00755-V.", "ArticleIdList": ["10.1016/0014-2999(94)00755-V", "7737339"]}, {"Citation": "Erd\u00f5 S.L., Moln\u00e1r P., Lakics V., Bence J.Z., T\u00f6m\u00f6sk\u00f6zi Z. Vincamine and vincanol are potent blockers of voltage-gated Na+ channels. Eur. J. Pharmacol. 1996;314:69\u201373. doi: 10.1016/S0014-2999(96)00542-0.", "ArticleIdList": ["10.1016/S0014-2999(96)00542-0", "8957220"]}, {"Citation": "Chiu P.J.S., Tetzloff G., Ahn H.-S., Sybertz E.J. Comparative Effects of Vinpocetine and 8-Br-Cyclic GMP on the Contraction and 45Ca-Fluxes in the Rabbit Aorta. Am. J. Hypertens. 1988;1:262\u2013268. doi: 10.1093/ajh/1.3.262.", "ArticleIdList": ["10.1093/ajh/1.3.262", "2455529"]}, {"Citation": "Milusheva E., Sperl\u00e1gh B., Kiss B., Szporny L., P\u00e1sztor E., Papasova M., Vizi E.S. Inhibitory effect of hypoxic condition on acetylcholine release is partly due to the effect of adenosine released from the tissue. Brain Res. Bull. 1990;24:369\u2013373. doi: 10.1016/0361-9230(90)90091-D.", "ArticleIdList": ["10.1016/0361-9230(90)90091-D", "2337817"]}, {"Citation": "Miyamoto M., Murphy T.H., Schnaar R.L., Coyle J.T. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 1989;250:1132\u20131140.", "ArticleIdList": ["2778712"]}, {"Citation": "Krieglstein J., Rischke R. Vinpocetine increases the neuroprotective effect of adenosine in vitro. Eur. J. Pharmacol. 1991;205:7\u201310. doi: 10.1016/0014-2999(91)90762-F.", "ArticleIdList": ["10.1016/0014-2999(91)90762-F", "1811999"]}, {"Citation": "Patyar S., Prakash A., Modi M., Medhi B. Role of vinpocetine in cerebrovascular diseases. Pharmacol. Rep. 2011;63:618\u2013628. doi: 10.1016/S1734-1140(11)70574-6.", "ArticleIdList": ["10.1016/S1734-1140(11)70574-6", "21857073"]}, {"Citation": "Li J., Chen F., Hu C., He L., Yan K., Zhou L., Pan W. Optimized Preparation of in Situ Forming Microparticles for the Parenteral Delivery of Vinpocetine. Chem. Pharm. Bull. 2008;56:796\u2013801. doi: 10.1248/cpb.56.796.", "ArticleIdList": ["10.1248/cpb.56.796", "18520083"]}, {"Citation": "Vas \u00c1., Guly\u00e1s B. Eburnamine derivatives and the brain. Med. Res. Rev. 2005;25:737\u2013757. doi: 10.1002/med.20043.", "ArticleIdList": ["10.1002/med.20043", "16158388"]}, {"Citation": "Willson C. Reference Module in Biomedical Sciences. Elsevier; Amsterdam, The Netherlands: 2015. Vinpocetine.", "ArticleIdList": ["10.1016/B978-0-12-801238-3.99480-7"]}, {"Citation": "Avula B., Chittiboyina A.G., Sagi S., Wang Y.-H., Wang M., Khan I.A., Cohen P.A. Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States. Drug Test. Anal. 2016;8:334\u2013343. doi: 10.1002/dta.1853.", "ArticleIdList": ["10.1002/dta.1853", "26426301"]}, {"Citation": "Cohen P.A. Vinpocetine: An Unapproved Drug Sold as a Dietary Supplement. Mayo Clin. Proc. 2015;90:1455. doi: 10.1016/j.mayocp.2015.07.008.", "ArticleIdList": ["10.1016/j.mayocp.2015.07.008", "26434971"]}, {"Citation": "Waidyanatha S., Toy H., South N., Gibbs S., Mutlu E., Burback B., McIntyre B.S., Catlin N. Systemic exposure of vinpocetine in pregnant Sprague Dawley rats following repeated oral exposure: An investigation of fetal transfer. Toxicol. Appl. Pharmacol. 2018;338:83\u201392. doi: 10.1016/j.taap.2017.11.011.", "ArticleIdList": ["10.1016/j.taap.2017.11.011", "PMC7063504", "29155086"]}, {"Citation": "Louis J.-C. Effect of naftidrofuryl on metabolism and survival of cultured neurons. Neurochem. Res. 1989;14:1195\u20131201. doi: 10.1007/BF00965509.", "ArticleIdList": ["10.1007/BF00965509", "2560818"]}, {"Citation": "Meynaud A., Grand M., Fontaine L. Effect of naftidrofuryl upon energy metabolism of the brain. Arzneimittelforschung. 1973;23:1431\u20131436.", "ArticleIdList": ["4360074"]}, {"Citation": "Toussaint O., Houbion A., Remacle J. Effects of modulations of the energetic metabolism on the mortality of cultured cells. Biochim. Biophys. Acta Bioenerg. 1994;1186:209\u2013220. doi: 10.1016/0005-2728(94)90180-5.", "ArticleIdList": ["10.1016/0005-2728(94)90180-5", "8043593"]}, {"Citation": "Barradas M.A., Stansby G., Hamilton G., Mikhailidis D.P. Effect of naftidrofuryl and aspirin on platelet aggregation in peripheral vascular disease. In Vivo. 1993;7:543\u2013548.", "ArticleIdList": ["8193274"]}, {"Citation": "Kirsten R., Erdeg B., Moxter D., Hesse K., Breidert M., Nelson K. Platelet aggregation after naftidrofuryl application in vitro and ex vivo. Int. J. Clin. Pharmacol. Ther. 1995;33:81\u201384.", "ArticleIdList": ["7757315"]}, {"Citation": "Nabeshima T., Hiramatsu M., Niwa K., Fuji K., Kameyama T. Effect of naftidrofuryl oxalate on 5-HT2 receptors in mouse brain: Evaluation based on quantitative autoradiography and head-twitch response. Eur. J. Pharmacol. 1992;223:109\u2013115. doi: 10.1016/0014-2999(92)94828-J.", "ArticleIdList": ["10.1016/0014-2999(92)94828-J", "1478263"]}, {"Citation": "Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) Pharmacol. Rev. 1994;46:157\u2013203.", "ArticleIdList": ["7938165"]}, {"Citation": "Plotkine M., Massad L., Allix M., Boulu R.G. A new arterial thrombosis model to study antithrombotic agents: Efficacy of naftidrofuryl. Clin. Hemorheol. Microcirc. 1989;9:339\u2013349. doi: 10.3233/CH-1989-9218.", "ArticleIdList": ["10.3233/CH-1989-9218"]}, {"Citation": "Kienbaum P., Braun M., Hohlfeld T., Weber A.A., Sarbia M., Schr\u00f6r K. Antiatherosclerotic effects of oral naftidrofuryl in cholesterol-fed rabbits involve inhibition of neutrophil function. J. Cardiovasc. Pharmacol. 1995;25:774\u2013781. doi: 10.1097/00005344-199505000-00013.", "ArticleIdList": ["10.1097/00005344-199505000-00013", "7543172"]}, {"Citation": "Ogawa S.-i., Kameyama T., Nabeshima T. Naftidrofuryl oxalate, nootropic effects on the scopolamine- and the basal forebrain lesion-induced amnesia in rats. Pharmacol. Biochem. Behav. 1991;39:997\u20131002. doi: 10.1016/0091-3057(91)90065-A.", "ArticleIdList": ["10.1016/0091-3057(91)90065-A", "1763119"]}, {"Citation": "Jung F., Kiesewetter H., Mrowietz C., Leipnitz G., Braun B., Wappler M., Scheffler P., Wenzel E. Hemorrheological, micro- and macrocirculatory effects of naftidrofuryl in an acute study: A randomized, placebo-controlled, double-blind individual comparison. Int. J. Clin. Pharmacol. Ther. Toxicol. 1987;25:507\u2013514.", "ArticleIdList": ["3679623"]}, {"Citation": "Shaw S.W.J., Johnson R.H. The Effect of Naftidrofuryl on the Metabolic Response to Exercise in Man. Acta Neurol. Scand. 1975;52:231\u2013237. doi: 10.1111/j.1600-0404.1975.tb05777.x.", "ArticleIdList": ["10.1111/j.1600-0404.1975.tb05777.x", "1155038"]}, {"Citation": "De Backer T., Vander Stichele R., Lehert P., Van Bortel L. Naftidrofuryl for intermittent claudication: Meta-analysis based on individual patient data. BMJ. 2009;338:b603. doi: 10.1136/bmj.b603.", "ArticleIdList": ["10.1136/bmj.b603", "PMC2659292", "19276131"]}, {"Citation": "Yaman A., Yaman H. Complementary Medications (Statins, Nicergoline, Naftidrofuryl) in Dementia. In: Riederer P., Laux G., Nagatsu T., Le W., Riederer C., editors. NeuroPsychopharmacotherapy. Springer International Publishing; Cham, Switzerland: 2020. pp. 1\u201314.", "ArticleIdList": ["10.1007/978-3-319-56015-1_422-1"]}, {"Citation": "M\u00f6ller H.J., Hartmann A., Kessler C., Rainer M., Brown T., Gamand S., Lehert P. Naftidrofuryl in the treatment of vascular dementia. Eur. Arch. Psychiatry Clin. Neurosci. 2001;251:247\u2013254. doi: 10.1007/PL00007541.", "ArticleIdList": ["10.1007/PL00007541", "11881837"]}, {"Citation": "Cholongitas E., Papatheodoridis G.V., Mavrogiannaki A., Manesis E. Naftidrofuryl-induced liver injury. Am. J. Gastroenterol. 2003;98:1448\u20131450. doi: 10.1111/j.1572-0241.2003.07506.x.", "ArticleIdList": ["10.1111/j.1572-0241.2003.07506.x", "12818301"]}, {"Citation": "Stoll A., Hofmann A. Die Alkaloide der Ergotoxingruppe: Ergocristin, Ergokryptin und Ergocornin. (7. Mitteilung \u00fcber Mutterkornalkaloide) Helv. Chim. Acta. 1943;26:1570\u20131601. doi: 10.1002/hlca.19430260522.", "ArticleIdList": ["10.1002/hlca.19430260522"]}, {"Citation": "Wilbrandt R. Treatment of Hypertension With Hydergine: A Review of 200 Cases. Angiology. 1953;4:183\u2013194. doi: 10.1177/000331975300400301.", "ArticleIdList": ["10.1177/000331975300400301", "13058172"]}, {"Citation": "Ammon R., Sharma R., Gambert S.R., Lal Gupta K. Hydergine revisited: A statistical analysis of studies showing efficacy in the treatment of cognitively impaired elderly. AGE. 1995;18:5\u20139. doi: 10.1007/BF02434076.", "ArticleIdList": ["10.1007/BF02434076"]}, {"Citation": "Sticher O., Hamburger M. Albert Hofmann (1906\u20132008)\u2013an Obituary. Planta Med. 2008;74:791\u2013793. doi: 10.1055/s-2008-1081289.", "ArticleIdList": ["10.1055/s-2008-1081289", "18600602"]}, {"Citation": "Walovitch R.C., Ingram D.K., Spangler E.L., London E.D. Co-dergocrine, cerebral glucose utilization and maze performance in middle-aged rats. Pharmacol. Biochem. Behav. 1987;26:95\u2013101. doi: 10.1016/0091-3057(87)90540-5.", "ArticleIdList": ["10.1016/0091-3057(87)90540-5", "3562504"]}, {"Citation": "Nagasawa H., Kogure K., Kawashima K., Ido T., Itoh M., Hatazawa J.U.N. Effects of Co-Dergocrine Mesylate (Hydergine\u00ae) in Multi-Infarct Dementia as Evaluated by Positron Emission Tomography. Tohoku J. Exp. Med. 1990;162:225\u2013233. doi: 10.1620/tjem.162.225.", "ArticleIdList": ["10.1620/tjem.162.225", "2091324"]}, {"Citation": "B\u00fcy\u00fck\u00f6zt\u00fcrk A.l., Kan\u0131t L., Ers\u00f6z B., Mente\u015f G., Hariri N.\u0130. The effects of hydergine on the MAO activity of the aged and adult rat brain. Eur. Neuropsychopharmacol. 1995;5:527\u2013529. doi: 10.1016/0924-977X(95)80014-S.", "ArticleIdList": ["10.1016/0924-977X(95)80014-S", "8998407"]}, {"Citation": "S\u00f6zmen E.Y., Kanit L., Kutay F.Z., Hariri N.\u0130. Possible supportive effects of co-dergocrine mesylate on antioxidant enzyme systems in aged rat brain. Eur. Neuropsychopharmacol. 1998;8:13\u201316. doi: 10.1016/S0924-977X(97)00039-4.", "ArticleIdList": ["10.1016/S0924-977X(97)00039-4", "9452935"]}, {"Citation": "Imperato A., Obinu M.C., Dazzi L., Carta G., Mascia M.S., Casu M.A., Gessa G.L. Co-dergocrine (hydergine) regulates striatal and hippocampal acetylcholine release through D2; receptors. Neuroreport. 1994;5:674\u2013676. doi: 10.1097/00001756-199402000-00003.", "ArticleIdList": ["10.1097/00001756-199402000-00003", "7911040"]}, {"Citation": "Amenta F., Cavallotti C., Franch F., Ricci A. Muscarinic cholinergic receptors in the hippocampus of the aged rat: Effects of long-term hydergine administration. Arch. Int. Pharmacodyn. Ther. 1989;297:225\u2013234.", "ArticleIdList": ["2730238"]}, {"Citation": "Amenta D., Ferrante F., Franch F., Amenta F. Effects of Long-Term Hydergine\u00ae Administration on Lipofuscin Accumulation in Senescent Rat Brain. Gerontology. 1988;34:250\u2013256. doi: 10.1159/000212963.", "ArticleIdList": ["10.1159/000212963", "3220260"]}, {"Citation": "Szewczykowski J., Meyer J.S., Kondo A., Nomura F., Teraura T. Effects of ergot alkaloids (Hydergine) on cerebral hemodynamics and oxygen consumption in monkeys. J. Neurol. Sci. 1970;10:25\u201331. doi: 10.1016/0022-510X(70)90089-4.", "ArticleIdList": ["10.1016/0022-510X(70)90089-4", "4983718"]}, {"Citation": "Saletu B., Gr\u00fcnberger J., Anderer R. On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: Double-blind placebo-controlled quantitative EEG and psychometric studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 1990;28:510\u2013524.", "ArticleIdList": ["2086492"]}, {"Citation": "Schneider L.S., Olin J.T. Overview of Clinical Trials of Hydergine in Dementia. Arch. Neurol. 1994;51:787\u2013798. doi: 10.1001/archneur.1994.00540200063018.", "ArticleIdList": ["10.1001/archneur.1994.00540200063018", "8042927"]}, {"Citation": "Flynn B.L., Ranno A.E. Pharmacologic Management of Alzheimer Disease Part II: Antioxidants, Antihypertensives, and Ergoloid Derivatives. Ann. Pharmacother. 1999;33:188\u2013197. doi: 10.1345/aph.17172.", "ArticleIdList": ["10.1345/aph.17172", "10084415"]}, {"Citation": "Thompson T.L., Filley C.M., Mitchell W.D., Culig K.M., LoVerde M., Byyny R.L. Lack of Efficacy of Hydergine in Patients with Alzheimer\u2019s Disease. N. Engl. J. Med. 1990;323:445\u2013448. doi: 10.1056/NEJM199008163230704.", "ArticleIdList": ["10.1056/NEJM199008163230704", "2082953"]}, {"Citation": "Olpe H.R., Steinmann M.W. The effect of vincamine, hydergine and piracetam on the firing rate of locus coeruleus neurons. J. Neural Transm. 1982;55:101\u2013109. doi: 10.1007/BF01243753.", "ArticleIdList": ["10.1007/BF01243753", "7175517"]}, {"Citation": "Zoglio M.A., Maulding H.V. Complexes of Ergot Alkaloids and Derivatives II: Interaction of Dihydroergotoxine with Certain Xanthines. J. Pharm. Sci. 1970;59:215\u2013219. doi: 10.1002/jps.2600590215.", "ArticleIdList": ["10.1002/jps.2600590215", "4983483"]}, {"Citation": "Cannon J.G. Burger\u2019s Medicinal Chemistry and Drug Discovery. Spring; Berlin/Heidelberg, Germany: 1984. Cholinergics; pp. 39\u2013108.", "ArticleIdList": ["10.1002/0471266949.bmc094"]}, {"Citation": "White H.L., Scates P.W. Acetyl-L-carnitine as a precursor of acetylcholine. Neurochem. Res. 1990;15:597\u2013601. doi: 10.1007/BF00973749.", "ArticleIdList": ["10.1007/BF00973749", "2215852"]}, {"Citation": "Heise G.A. Facilitation of memory and cognition by drugs. Trends Pharmacol. Sci. 1987;8:65\u201368. doi: 10.1016/0165-6147(87)90012-5.", "ArticleIdList": ["10.1016/0165-6147(87)90012-5"]}, {"Citation": "Fernandes G.D., Alberici R.M., Pereira G.G., Cabral E.C., Eberlin M.N., Barrera-Arellano D. Direct characterization of commercial lecithins by easy ambient sonic-spray ionization mass spectrometry. Food Chem. 2012;135:1855\u20131860. doi: 10.1016/j.foodchem.2012.06.072.", "ArticleIdList": ["10.1016/j.foodchem.2012.06.072", "22953933"]}, {"Citation": "Wendel A. Kirk-Othmer Encyclopedia of Chemical Technology. Wiley; New York, NY, USA: 2000. Lecithin.", "ArticleIdList": ["10.1002/0471238961.1205030923051404.a01"]}, {"Citation": "Canty D.J., Zeisel S.H. Lecithin and Choline in Human Health and Disease. Nutr. Rev. 1994;52:327\u2013339. doi: 10.1111/j.1753-4887.1994.tb01357.x.", "ArticleIdList": ["10.1111/j.1753-4887.1994.tb01357.x", "7816350"]}, {"Citation": "Chung S.-Y., Moriyama T., Uezu E., Uezu K., Hirata R., Yohena N., Masuda Y., Kokubu Y., Yamamoto S. Administration of Phosphatidylcholine Increases Brain Acetylcholine Concentration and Improves Memory in Mice with Dementia. J. Nutr. 1995;125:1484\u20131489. doi: 10.1093/jn/125.6.1484.", "ArticleIdList": ["10.1093/jn/125.6.1484", "7782901"]}, {"Citation": "Higgins J.P.T., Flicker L. Lecithin for dementia and cognitive impairment. Cochrane Database Syst. Rev. 2000 doi: 10.1002/14651858.CD001015.", "ArticleIdList": ["10.1002/14651858.CD001015", "10796586"]}, {"Citation": "Ladd S.L., Sommer S.A., LaBerge S., Toscano W. Effect of phosphatidylcholine on explicit memory. Clin. Neuropharmacol. 1993;16:540\u2013549. doi: 10.1097/00002826-199312000-00007.", "ArticleIdList": ["10.1097/00002826-199312000-00007", "9377589"]}, {"Citation": "Kulkarni R., Girish K.J., Kumar A. Nootropic herbs (Medhya Rasayana) in Ayurveda: An update. Pharmacogn. Rev. 2012;6:147\u2013153. doi: 10.4103/0973-7847.99949.", "ArticleIdList": ["10.4103/0973-7847.99949", "PMC3459457", "23055641"]}, {"Citation": "Dwivedi P., Singh R., Malik M.T., Jawaid T. A traditional approach to herbal nootropic agents: An overview. Int. J. Pharm. Sci. 2012;3:630\u2013636."}, {"Citation": "Zuin V.G., Vilegas J.H.Y. Pesticide residues in medicinal plants and phytomedicines. Phytother. Res. 2000;14:73\u201388. doi: 10.1002/(SICI)1099-1573(200003)14:2<73::AID-PTR577>3.0.CO;2-#.", "ArticleIdList": ["10.1002/(SICI)1099-1573(200003)14:2<73::AID-PTR577>3.0.CO;2-#", "10685102"]}, {"Citation": "Pandey A., Savita R. Harvesting and post-harvest processing of medicinal plants: Problems and prospects. J. Pharm. Innov. 2017;6:229\u2013235."}, {"Citation": "Mishra M., Kotwal P., Prasad C. Harvesting of medicinal plants in the forest of Central India and its impact on quality of raw materials: A case of Nagpur District, India. Ecoprint Int. J. Ecol. 2009;16:35\u201342. doi: 10.3126/eco.v16i0.3471.", "ArticleIdList": ["10.3126/eco.v16i0.3471"]}, {"Citation": "Harnischfeger G. Proposed Guidelines for Commercial Collection of Medicinal Plant Material. J. Herbs Spices Med. Plants. 2000;7:43\u201350. doi: 10.1300/J044v07n01_06.", "ArticleIdList": ["10.1300/J044v07n01_06"]}, {"Citation": "Tanko H., Carrier D.J., Duan L., Clausen E. Pre- and post-harvest processing of medicinal plants. Plant Genet. Res. 2005;3:304\u2013313. doi: 10.1079/PGR200569.", "ArticleIdList": ["10.1079/PGR200569"]}, {"Citation": "Belwal T., Cravotto C., Prieto M.A., Venskutonis P.R., Daglia M., Devkota H.P., Baldi A., Ezzat S.M., G\u00f3mez-G\u00f3mez L., Salama M.M., et al. Effects of different drying techniques on the quality and bioactive compounds of plant-based products: A critical review on current trends. Dry. 2022;40:1539\u20131561. doi: 10.1080/07373937.2022.2068028.", "ArticleIdList": ["10.1080/07373937.2022.2068028"]}, {"Citation": "Lewicki P.P. Effect of pre-drying treatment, drying and rehydration on plant tissue properties: A review. Int. J. Food Prop. 1998;1:1\u201322. doi: 10.1080/10942919809524561.", "ArticleIdList": ["10.1080/10942919809524561"]}, {"Citation": "Abascal K., Ganora L., Yarnell E. The effect of freeze-drying and its implications for botanical medicine: A review. Phytother. Res. 2005;19:655\u2013660. doi: 10.1002/ptr.1651.", "ArticleIdList": ["10.1002/ptr.1651", "16177965"]}, {"Citation": "Liapis A.I., Bruttini R. Freeze drying. In: Mujumdar A.S., editor. Handbook of Industrial Drying. CRC Press; Boca Raton, FL, USA: 2020. pp. 309\u2013343."}, {"Citation": "Wijesekera R. The Medicinal Plant Industry. Routledge; London, UK: 2017."}, {"Citation": "Fonmboh D.J., Abah E.R., Fokunang T.E., Herve B., Teke G.N., Rose N.M., Borgia N.N., Fokunang L.B., Andrew B.N., Kaba N. An overview of methods of extraction, isolation and characterization of natural medicinal plant products in improved traditional medicine research. Asian J. Res. Med. Pharm. Sci. 2020;9:31\u201357. doi: 10.9734/ajrimps/2020/v9i230152.", "ArticleIdList": ["10.9734/ajrimps/2020/v9i230152"]}, {"Citation": "Fu Y., Ji L.L. Chronic Ginseng Consumption Attenuates Age-Associated Oxidative Stress in Rats. J. Nutr. 2003;133:3603\u20133609. doi: 10.1093/jn/133.11.3603.", "ArticleIdList": ["10.1093/jn/133.11.3603", "14608081"]}, {"Citation": "Churchill J.D., Gerson J.L., Hinton K.A., Mifek J.L., Walter M.J., Winslow C.L., Deyo R.A. The nootropic properties of ginseng saponin Rb1 are linked to effects on anxiety. Integr. Physiol. Behav. Sci. 2002;37:178\u2013187. doi: 10.1007/BF02734180.", "ArticleIdList": ["10.1007/BF02734180", "12435210"]}, {"Citation": "Wang Y., Liu J., Zhang Z., Bi P., Qi Z., Zhang C. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease. Neurosci. Lett. 2011;487:70\u201372. doi: 10.1016/j.neulet.2010.09.076.", "ArticleIdList": ["10.1016/j.neulet.2010.09.076", "20933058"]}, {"Citation": "Yang L., Zhang J., Zheng K., Shen H., Chen X. Long-term Ginsenoside Rg1 Supplementation Improves Age-Related Cognitive Decline by Promoting Synaptic Plasticity Associated Protein Expression in C57BL/6J Mice. J. Gerontol. A. 2013;69A:282\u2013294. doi: 10.1093/gerona/glt091.", "ArticleIdList": ["10.1093/gerona/glt091", "23833204"]}, {"Citation": "Yu J., Eto M., Akishita M., Kaneko A., Ouchi Y., Okabe T. Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: A possible involvement of androgen receptor. Biochem. Biophys. Res. Commun. 2007;353:764\u2013769. doi: 10.1016/j.bbrc.2006.12.119.", "ArticleIdList": ["10.1016/j.bbrc.2006.12.119", "17196933"]}, {"Citation": "Diamond B.J., Shiflett S.C., Feiwel N., Matheis R.J., Noskin O., Richards J.A., Schoenberger N.E. Ginkgo biloba extract: Mechanisms and clinical indications. Arch. Phys. Med. Rehabil. 2000;81:668\u2013678. doi: 10.1016/S0003-9993(00)90052-2.", "ArticleIdList": ["10.1016/S0003-9993(00)90052-2", "10807109"]}, {"Citation": "Kim M.-S., Bang J.H., Lee J., Han J.-S., Baik T.G., Jeon W.K. Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system. Phytomedicine. 2016;23:1356\u20131364. doi: 10.1016/j.phymed.2016.07.013.", "ArticleIdList": ["10.1016/j.phymed.2016.07.013", "27765355"]}, {"Citation": "Nishimon S., Yamaguchi M., Muraki H., Sakai N., Nishino S. Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice. Neurosci. Lett. 2020;722:134832. doi: 10.1016/j.neulet.2020.134832.", "ArticleIdList": ["10.1016/j.neulet.2020.134832", "32050100"]}, {"Citation": "Stough C., Clarke J., Lloyd J., Nathan P.J. Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. Int. J. Neuropsychopharmacol. 2001;4:131\u2013134. doi: 10.1017/S1461145701002292.", "ArticleIdList": ["10.1017/S1461145701002292", "11466162"]}, {"Citation": "Valli G., Giardina E.-G.V. Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects. J. Am. Coll. Cardiol. 2002;39:1083\u20131095. doi: 10.1016/S0735-1097(02)01749-7.", "ArticleIdList": ["10.1016/S0735-1097(02)01749-7", "11923030"]}, {"Citation": "Chanana P., Kumar A. Possible Involvement of Nitric Oxide Modulatory Mechanisms in the Neuroprotective Effect of Centella asiatica Against Sleep Deprivation Induced Anxiety Like Behaviour, Oxidative Damage and Neuroinflammation. Phytother. Res. 2016;30:671\u2013680. doi: 10.1002/ptr.5582.", "ArticleIdList": ["10.1002/ptr.5582", "26848139"]}, {"Citation": "Chen C.-L., Tsai W.-H., Chen C.-J., Pan T.-M. Centella asiatica extract protects against amyloid \u03b21\u201340-induced neurotoxicity in neuronal cells by activating the antioxidative defence system. J. Tradit. Complement. Med. 2016;6:362\u2013369. doi: 10.1016/j.jtcme.2015.07.002.", "ArticleIdList": ["10.1016/j.jtcme.2015.07.002", "PMC5067859", "27774420"]}, {"Citation": "Rao S.B., Chetana M., Uma Devi P. Centella asiatica treatment during postnatal period enhances learning and memory in mice. Physiol. Behav. 2005;86:449\u2013457. doi: 10.1016/j.physbeh.2005.07.019.", "ArticleIdList": ["10.1016/j.physbeh.2005.07.019", "16214185"]}, {"Citation": "Bhattacharya S.K., Kumar A., Ghosal S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer\u2019s disease and perturbed central cholinergic markers of cognition in rats. Phytother. Res. 1995;9:110\u2013113. doi: 10.1002/ptr.2650090206.", "ArticleIdList": ["10.1002/ptr.2650090206"]}, {"Citation": "Naidu P.S., Singh A., Kulkarni S.K. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother. Res. 2006;20:140\u2013146. doi: 10.1002/ptr.1823.", "ArticleIdList": ["10.1002/ptr.1823", "16444668"]}, {"Citation": "Schliebs R., Liebmann A., Bhattacharya S.K., Kumar A., Ghosal S., Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem. Int. 1997;30:181\u2013190. doi: 10.1016/S0197-0186(96)00025-3.", "ArticleIdList": ["10.1016/S0197-0186(96)00025-3", "9017665"]}, {"Citation": "Ziauddin M., Phansalkar N., Patki P., Diwanay S., Patwardhan B. Studies on the immunomodulatory effects of Ashwagandha. J. Ethnopharmacol. 1996;50:69\u201376. doi: 10.1016/0378-8741(95)01318-0.", "ArticleIdList": ["10.1016/0378-8741(95)01318-0", "8866726"]}, {"Citation": "Le X.T., Pham H.T.N., Do P.T., Fujiwara H., Tanaka K., Li F., Van Nguyen T., Nguyen K.M., Matsumoto K. Bacopa monnieri Ameliorates Memory Deficits in Olfactory Bulbectomized Mice: Possible Involvement of Glutamatergic and Cholinergic Systems. Neurochem. Res. 2013;38:2201\u20132215. doi: 10.1007/s11064-013-1129-6.", "ArticleIdList": ["10.1007/s11064-013-1129-6", "23949198"]}, {"Citation": "Russo A., Borrelli F., Campisi A., Acquaviva R., Raciti G., Vanella A. Nitric oxide-related toxicity in cultured astrocytes: Effect of Bacopa monniera. Life Sci. 2003;73:1517\u20131526. doi: 10.1016/S0024-3205(03)00476-4.", "ArticleIdList": ["10.1016/S0024-3205(03)00476-4", "12865091"]}, {"Citation": "Singh H., Dhawan B. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn.(Brahmi) Indian J. Pharmacol. 1997;29:359."}, {"Citation": "Uabundit N., Wattanathorn J., Mucimapura S., Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer\u2019s disease model. J. Ethnopharmacol. 2010;127:26\u201331. doi: 10.1016/j.jep.2009.09.056.", "ArticleIdList": ["10.1016/j.jep.2009.09.056", "19808086"]}, {"Citation": "Espinola E.B., Dias R.F., Mattei R., Carlini E.A. Pharmacological activity of Guarana (Paullinia cupana Mart.) in laboratory animals. J. Ethnopharmacol. 1997;55:223\u2013229. doi: 10.1016/S0378-8741(96)01506-1.", "ArticleIdList": ["10.1016/S0378-8741(96)01506-1", "9080343"]}, {"Citation": "Otobone F.J., Sanches A.C., Nagae R.L., Martins J.V.C., Obici S., Mello J.C.P.d., Audi E.A. Effect of crude extract and its semi purified constituents from guaran\u00e1 seeds [Paullinia cupana var. sorbilis (Mart.) lucke] on cognitive performance in Morris water maze in rats. Braz. Arch. Biol. Technol. 2005;48:723\u2013728. doi: 10.1590/S1516-89132005000600007.", "ArticleIdList": ["10.1590/S1516-89132005000600007"]}, {"Citation": "Cropley M., Banks A.P., Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother. Res. 2015;29:1934\u20131939. doi: 10.1002/ptr.5486.", "ArticleIdList": ["10.1002/ptr.5486", "26502953"]}, {"Citation": "Perfumi M., Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother. Res. 2007;21:37\u201343. doi: 10.1002/ptr.2013.", "ArticleIdList": ["10.1002/ptr.2013", "17072830"]}, {"Citation": "Yu S., Liu M., Gu X., Ding F. Neuroprotective Effects of Salidroside in the PC12 Cell Model Exposed to Hypoglycemia and Serum Limitation. Cell Mol. Neurobiol. 2008;28:1067\u20131078. doi: 10.1007/s10571-008-9284-z.", "ArticleIdList": ["10.1007/s10571-008-9284-z", "18481168"]}, {"Citation": "Sa F., Zhang L.Q., Chong C.M., Guo B.J., Li S., Zhang Z.J., Zheng Y., Hoi P.M., Lee S.M.Y. Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo. Neurosci. Lett. 2015;593:7\u201312. doi: 10.1016/j.neulet.2015.03.016.", "ArticleIdList": ["10.1016/j.neulet.2015.03.016", "25770828"]}, {"Citation": "Yan T., Shang L., Wang M., Zhang C., Zhao X., Bi K., Jia Y. Lignans from Schisandra chinensis ameliorate cognition deficits and attenuate brain oxidative damage induced by D-galactose in rats. Metab. Brain Dis. 2016;31:653\u2013661. doi: 10.1007/s11011-016-9804-3.", "ArticleIdList": ["10.1007/s11011-016-9804-3", "26847610"]}, {"Citation": "Zhang L.Q., Sa F., Chong C.M., Wang Y., Zhou Z.Y., Chang R.C.C., Chan S.W., Hoi P.M., Yuen Lee S.M. Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3\u03b2 pathways. J. Ethnopharmacol. 2015;170:8\u201315. doi: 10.1016/j.jep.2015.04.040.", "ArticleIdList": ["10.1016/j.jep.2015.04.040", "25934514"]}, {"Citation": "Bajpai V.K., Sharma A., Kim S.H., Kim Y., Kim J.-J., Baeak K.-H. Microwave-Assisted seed essential oil of eleutherococcus senticosus and its antioxidant and free radical-scavenging activities. J. Food Biochem. 2013;37:119\u2013127. doi: 10.1111/jfbc.12013.", "ArticleIdList": ["10.1111/jfbc.12013"]}, {"Citation": "Gromovaya V.F., Shapoval G.S., Mironyuk I.E., Nestyuk N.V. Antioxidant properties of medicinal plants. Pharm. Chem. J. 2008;42:25\u201328. doi: 10.1007/s11094-008-0050-9.", "ArticleIdList": ["10.1007/s11094-008-0050-9"]}, {"Citation": "Szo\u0142omicki S., Samochowiec L., W\u00f3jcicki J., Dro\u017adzik M. The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in man. Phytother. Res. 2000;14:30\u201335. doi: 10.1002/(SICI)1099-1573(200002)14:1<30::AID-PTR543>3.0.CO;2-V.", "ArticleIdList": ["10.1002/(SICI)1099-1573(200002)14:1<30::AID-PTR543>3.0.CO;2-V", "10641044"]}, {"Citation": "Takasugi N., Moriguchi T., Fuwa T., Sanada S., Ida Y., Shoji J., Saito H. Effect of Eleutherococcus senticosus and its components on rectal temperature, body and grip tones, motor coordination, and exploratory and spontaneous movements in acute stressed mice. Pharmacogn. Mag. 1985;39:232\u2013237."}, {"Citation": "Yamauchi Y., Ge Y.-W., Yoshimatsu K., Komatsu K., Kuboyama T., Yang X., Tohda C. Memory Enhancement by Oral Administration of Extract of Eleutherococcus senticosus Leaves and Active Compounds Transferred in the Brain. Nutrients. 2019;11:1142. doi: 10.3390/nu11051142.", "ArticleIdList": ["10.3390/nu11051142", "PMC6567285", "31121888"]}, {"Citation": "Caicai K., Limin H., Liming Z., Zhiqiang Z., Yongwu Y. Isolation, purification and antioxidant activity of polysaccharides from the leaves of maca (Lepidium Meyenii) Int. J. Biol. Macromol. 2018;107:2611\u20132619. doi: 10.1016/j.ijbiomac.2017.10.139.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.10.139", "29080819"]}, {"Citation": "Guo S.-S., Gao X.-F., Gu Y.-R., Wan Z.-X., Lu A.M., Qin Z.-H., Luo L. Preservation of Cognitive Function by Lepidium meyenii (Maca) Is Associated with Improvement of Mitochondrial Activity and Upregulation of Autophagy-Related Proteins in Middle-Aged Mouse Cortex. J. Evid. Based Complement. Altern. Med. 2016;2016:4394261. doi: 10.1155/2016/4394261.", "ArticleIdList": ["10.1155/2016/4394261", "PMC5018343", "27648102"]}, {"Citation": "Rubio J., Caldas M., D\u00e1vila S., Gasco M., Gonzales G.F. Effect of three different cultivars of Lepidium meyenii (Maca) on learning and depression in ovariectomized mice. BMC Complement. Altern. Med. 2006;6:23. doi: 10.1186/1472-6882-6-23.", "ArticleIdList": ["10.1186/1472-6882-6-23", "PMC1534053", "16796734"]}, {"Citation": "Ha D.-C., Ryu G.-H. Chemical components of red, white and extruded root ginseng. J. Korean Soc. Food Sci. Nutr. 2005;34:247\u2013254. doi: 10.3746/jkfn.2005.34.2.247.", "ArticleIdList": ["10.3746/jkfn.2005.34.2.247"]}, {"Citation": "Petkov V.D., Belcheva S., Konstantinova E., Kehayov R., Petkov V.V., Hadjiivanova C. Participation of the serotonergic system in the memory effects of Ginkgo biloba L. and Panax ginseng C. A. Mey. Phytother. Res. 1994;8:470\u2013477. doi: 10.1002/ptr.2650080807.", "ArticleIdList": ["10.1002/ptr.2650080807"]}, {"Citation": "Nocerino E., Amato M., Izzo A.A. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia. 2000;71:S1\u2013S5. doi: 10.1016/S0367-326X(00)00170-2.", "ArticleIdList": ["10.1016/S0367-326X(00)00170-2", "10930706"]}, {"Citation": "Kiefer D.S., Pantuso T. Panax ginseng. Am. Fam. Physician. 2003;68:1539\u20131542.", "ArticleIdList": ["14596440"]}, {"Citation": "Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177.", "ArticleIdList": ["10.3389/fphar.2013.00177", "PMC3887317", "24454289"]}, {"Citation": "Masteikova R., Muselik J., Bernatonien\u0117 J., Bernatonien\u0117 R. Antioxidative activity of Ginkgo, Echinacea, and Ginseng tinctures. Medicina. 2007;43:306. doi: 10.3390/medicina43040038.", "ArticleIdList": ["10.3390/medicina43040038", "17485958"]}, {"Citation": "Boateng I.D., Yang X.-M. Effect of different drying methods on product quality, bioactive and toxic components of Ginkgo biloba L. seed. J. Sci. Food Agric. 2021;101:3290\u20133297. doi: 10.1002/jsfa.10958.", "ArticleIdList": ["10.1002/jsfa.10958", "33222187"]}, {"Citation": "Canter P., Ernst E. Ginkgo biloba is not a smart drug: An updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Hum. Psychopharmacol. 2007;22:265\u2013278. doi: 10.1002/hup.843.", "ArticleIdList": ["10.1002/hup.843", "17480002"]}, {"Citation": "Le Bars P.L., Kastelan J. Efficacy and safety of a Ginkgo biloba extract. Public Health Nutr. 2000;3:495\u2013499. doi: 10.1017/S1368980000000574.", "ArticleIdList": ["10.1017/S1368980000000574", "11276297"]}, {"Citation": "EGb 761 . Drugs R & D. Volume 4. Springer; Berlin/Heidelberg, Germany: 2003. pp. 188\u2013193.", "ArticleIdList": ["10.2165/00126839-200304030-00009", "12757407"]}, {"Citation": "Mahady G.B. Ginkgo Biloba: A Review of Quality, Safety, and Efficacy. Nutr. Clin. Care. 2001;4:140\u2013147. doi: 10.1046/j.1523-5408.2001.00135.x.", "ArticleIdList": ["10.1046/j.1523-5408.2001.00135.x"]}, {"Citation": "Jayasinghe M., Senadheera S., Wijesekara I., Ranaweera K. Determination of macronutrient compositions in selected, frequently consumed leafy vegetables, prepared according to common culinary methods in Sri Lanka. Vidyodaya J. Sci. 2019;22:816\u2013820. doi: 10.31357/vjs.v22i2.4384.", "ArticleIdList": ["10.31357/vjs.v22i2.4384", "PMC7026327", "32123401"]}, {"Citation": "Wijeweera P., Arnason J.T., Koszycki D., Merali Z. Evaluation of anxiolytic properties of Gotukola\u2014(Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine. 2006;13:668\u2013676. doi: 10.1016/j.phymed.2006.01.011.", "ArticleIdList": ["10.1016/j.phymed.2006.01.011", "16488124"]}, {"Citation": "Gohil K.J., Patel J.A., Gajjar A.K. Pharmacological Review on Centella asiatica: A Potential Herbal Cure-all. Indian J. Pharm. Sci. 2010;72:546\u2013556. doi: 10.4103/0250-474X.78519.", "ArticleIdList": ["10.4103/0250-474X.78519", "PMC3116297", "21694984"]}, {"Citation": "Anukunwithaya T., Tantisira M.H., Tantisira B., Khemawoot P. Pharmacokinetics of a standardized extract of Centella asiatica ECa 233 in rats. Planta Med. 2017;83:710\u2013717. doi: 10.1055/s-0042-122344.", "ArticleIdList": ["10.1055/s-0042-122344", "27992940"]}, {"Citation": "Brinkhaus B., Lindner M., Schuppan D., Hahn E.G. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella aslatica. Phytomedicine. 2000;7:427\u2013448. doi: 10.1016/S0944-7113(00)80065-3.", "ArticleIdList": ["10.1016/S0944-7113(00)80065-3", "11081995"]}, {"Citation": "Bamola N., Verma P., Negi C. A review on some traditional medicinal plants. Int. J. Life Sci. Res. 2018;4:1550\u20131556. doi: 10.21276/ijlssr.2018.4.1.7.", "ArticleIdList": ["10.21276/ijlssr.2018.4.1.7"]}, {"Citation": "Patel K., Singh R.B., Patel D.K. Pharmacological and analytical aspects of withaferin A: A concise report of current scientific literature. Asian Pac. J. Reprod. 2013;2:238\u2013243. doi: 10.1016/S2305-0500(13)60154-2.", "ArticleIdList": ["10.1016/S2305-0500(13)60154-2"]}, {"Citation": "Raut A.A., Rege N.N., Tadvi F.M., Solanki P.V., Kene K.R., Shirolkar S.G., Pandey S.N., Vaidya R.A., Vaidya A.B. Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers. J. Ayurveda Integr. Med. 2012;3:111\u2013114. doi: 10.4103/0975-9476.100168.", "ArticleIdList": ["10.4103/0975-9476.100168", "PMC3487234", "23125505"]}, {"Citation": "Meher S.K., Das B., Panda P., Bhuyan G.C., Rao M.M. Uses of Withania somnifera (Linn) Dunal (Ashwagandha) in Ayurveda and its pharmacological evidences. Res. J. Pharmacol. Pharmacodyn. 2016;8:23\u201329. doi: 10.5958/2321-5836.2016.00006.9.", "ArticleIdList": ["10.5958/2321-5836.2016.00006.9"]}, {"Citation": "Chadha M.L. Indigenous vegetables of India with potentials for improving livelihood. Acta Hortic. 2009;806:579\u2013586. doi: 10.17660/ActaHortic.2009.806.72.", "ArticleIdList": ["10.17660/ActaHortic.2009.806.72"]}, {"Citation": "Devendra P., Patel S.S., Birwal P., Basu S., Deshmukh G., Datir R. Brahmi (Bacopa monnieri) as functional food ingredient in food processing industry. J. Pharmacogn. Phytochem. 2018;7:189\u2013194."}, {"Citation": "Gohil K.J., Patel J.A. A review on Bacopa monniera: Current research and future prospects. Int. J. Green Pharm. 2010;4:1\u20139. doi: 10.4103/0973-8258.62156.", "ArticleIdList": ["10.4103/0973-8258.62156"]}, {"Citation": "Russo A., Borrelli F. Bacopa monniera, a reputed nootropic plant: An overview. Phytomedicine. 2005;12:305\u2013317. doi: 10.1016/j.phymed.2003.12.008.", "ArticleIdList": ["10.1016/j.phymed.2003.12.008", "15898709"]}, {"Citation": "Kean J.D., Downey L.A., Stough C. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations. Complement. Ther. Med. 2016;29:56\u201362. doi: 10.1016/j.ctim.2016.09.002.", "ArticleIdList": ["10.1016/j.ctim.2016.09.002", "27912958"]}, {"Citation": "Cavalcanti V., Marques M., Do Nascimento W.M., Rocha A.W.D.O., Ferreira I.D.J., Le\u00e3o D.P., F\u00e9lix P.H.C., De Oliveira C.M.C. Bioproducts based on guarana (Paulinia cupana) for practitioners of physical activity. Eur. Acad. Res. 2020;8:1746\u20131759."}, {"Citation": "Banga S., Kumar V., Suri S., Kaushal M., Prasad R., Kaur S. Nutraceutical Potential of Diet Drinks: A Critical Review on Components, Health Effects, and Consumer Safety. J. Am. Coll. Nutr. 2020;39:272\u2013286. doi: 10.1080/07315724.2019.1642811.", "ArticleIdList": ["10.1080/07315724.2019.1642811", "31343956"]}, {"Citation": "Rangel M.P., De Mello J.C.P., Audi E.A. Evaluation of neurotransmitters involved in the anxiolytic and panicolytic effect of the aqueous fraction of Paullinia cupana (guaran\u00e1) in elevated T maze. Rev. Bras. Farmacogn. 2013;23:358\u2013365. doi: 10.1590/S0102-695X2013005000024.", "ArticleIdList": ["10.1590/S0102-695X2013005000024"]}, {"Citation": "Kennedy D.O., Haskell C.F., Wesnes K.A., Scholey A.B. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: Comparison and interaction with Panax ginseng. Pharmacol. Biochem. Behav. 2004;79:401\u2013411. doi: 10.1016/j.pbb.2004.07.014.", "ArticleIdList": ["10.1016/j.pbb.2004.07.014", "15582012"]}, {"Citation": "Marques L.L.M., Klein T., De Mello J.C.P. Chapter 3.24\u2014Guarana. In: Nabavi S.M., Silva A.S., editors. Nonvitamin and Nonmineral Nutritional Supplements. Academic Press; New York, NY, USA: 2019. pp. 283\u2013288.", "ArticleIdList": ["10.1016/B978-0-12-812491-8.00040-0"]}, {"Citation": "Davydov M., Krikorian A.D. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: A closer look. J. Ethnopharmacol. 2000;72:345\u2013393. doi: 10.1016/S0378-8741(00)00181-1.", "ArticleIdList": ["10.1016/S0378-8741(00)00181-1", "10996277"]}, {"Citation": "Gerontakos S., Taylor A., Avdeeva A.Y., Shikova V.A., Pozharitskaya O.N., Casteleijn D., Wardle J., Shikov A.N. Findings of Russian literature on the clinical application of Eleutherococcus senticosus (Rupr. & Maxim.): A narrative review. J. Ethnopharmacol. 2021;278:114274. doi: 10.1016/j.jep.2021.114274.", "ArticleIdList": ["10.1016/j.jep.2021.114274", "34087398"]}, {"Citation": "Mahady G.B., Gyllenhaal C., Fong H.H., Farnsworth N.R. Ginsengs: A Review of Safety and Efficacy. Nutr. Clin. Care. 2000;3:90\u2013101. doi: 10.1046/j.1523-5408.2000.00020.x.", "ArticleIdList": ["10.1046/j.1523-5408.2000.00020.x"]}, {"Citation": "Bleakney T.L. Deconstructing an Adaptogen: Eleutherococcus senticosus. Holist. Nurs. Pract. 2008;22:220\u2013224. doi: 10.1097/01.HNP.0000326005.65310.7c.", "ArticleIdList": ["10.1097/01.HNP.0000326005.65310.7c", "18607235"]}, {"Citation": "Schmidt M., Thomsen M., Kelber O., Kraft K. Myths and facts in herbal medicines: Eleutherococcus senticosus (Siberian ginseng) and its contraindication in hypertensive patients. Botanics. 2014;4:27\u201332. doi: 10.2147/BTAT.S60734.", "ArticleIdList": ["10.2147/BTAT.S60734"]}, {"Citation": "Ko\u0142odziej B., Sugier D. Influence of plants age on the chemical composition of roseroot (Rhodiola rosea L.) Acta Sci. Pol. 2013;12:147\u2013160."}, {"Citation": "Gregory S., Kelly N. Rhodiola rosea: A Possible Plant Adaptogen. Altern. Med. Rev. 2001;6:293\u2013302.", "ArticleIdList": ["11410073"]}, {"Citation": "Jagtap P.N., Mhetre O.S., Malavdkar P.R. A Review Article on Rhodiola Rosea: An Adaptogen Having Multiple Benefits. Int. J. Pharmacogn. 2020;7:62\u201369. doi: 10.13040/IJPSR.0975-8232.IJP.7(3).62-69.", "ArticleIdList": ["10.13040/IJPSR.0975-8232.IJP.7(3).62-69"]}, {"Citation": "Panossian A., Wikman G. Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine. J. Ethnopharmacol. 2008;118:183\u2013212. doi: 10.1016/j.jep.2008.04.020.", "ArticleIdList": ["10.1016/j.jep.2008.04.020", "18515024"]}, {"Citation": "Liu X., Guo Y., Cai G., Gong J., Wang Y., Liu S. Chemical composition analysis of Schisandra chinensis fructus and its three processed products using UHPLC-Q-Orbitrap/MS-based metabolomics approach. Nat. Prod. Res. 2020;36:3464\u20133468. doi: 10.1080/14786419.2020.1858416.", "ArticleIdList": ["10.1080/14786419.2020.1858416", "33297729"]}, {"Citation": "Li N., Liu C., Jing S., Wang M., Wang H., Sun J., Wang C., Chen J., Li H. Compound Schisandra-Ginseng-Notoginseng-Lycium Extract Ameliorates Scopolamine-Induced Learning and Memory Disorders in Mice. Evid. Based Complement. Altern. Med. 2017;2017:8632016. doi: 10.1155/2017/8632016.", "ArticleIdList": ["10.1155/2017/8632016", "PMC5549506", "28814961"]}, {"Citation": "Zovko Koncic M., Tomczyk M. New insights into dietary supplements used in sport: Active substances, pharmacological and side effects. Curr. Drug Targets. 2013;14:1079\u20131092. doi: 10.2174/1389450111314090016.", "ArticleIdList": ["10.2174/1389450111314090016", "23574283"]}, {"Citation": "Brinckmann J., Smith E. Maca Culture of the Jun\u00edn Plateau. J. Altern. Complement. Med. 2004;10:426\u2013430. doi: 10.1089/1075553041323821.", "ArticleIdList": ["10.1089/1075553041323821", "15253845"]}, {"Citation": "Smith E. Maca root: Modern Rediscovery of An Ancient Andean Fertility Food. J. Am. Herb. Guild. 2004;4:15\u201321."}, {"Citation": "Gonzales G.F., C\u00f3rdova A., Vega K., Chung A., Villena A., G\u00f3\u00f1ez C., Castillo S. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia. 2002;34:367\u2013372. doi: 10.1046/j.1439-0272.2002.00519.x.", "ArticleIdList": ["10.1046/j.1439-0272.2002.00519.x", "12472620"]}, {"Citation": "Gonzales-Arimborgo C., Yupanqui I., Montero E., Alarc\u00f3n-Yaquetto D.E., Zevallos-Concha A., Caballero L., Gasco M., Zhao J., Khan I.A., Gonzales G.F. Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study. Pharmaceuticals. 2016;9:49. doi: 10.3390/ph9030049.", "ArticleIdList": ["10.3390/ph9030049", "PMC5039502", "27548190"]}, {"Citation": "West E., Krychman M. Natural Aphrodisiacs\u2014A Review of Selected Sexual Enhancers. Sex. Med. Rev. 2015;3:279\u2013288. doi: 10.1002/smrj.62.", "ArticleIdList": ["10.1002/smrj.62", "27784600"]}, {"Citation": "Turnbull D., Rodricks J.V., Mariano G.F., Chowdhury F. Caffeine and cardiovascular health. Regul. Toxicol. Pharmacol. 2017;89:165\u2013185. doi: 10.1016/j.yrtph.2017.07.025.", "ArticleIdList": ["10.1016/j.yrtph.2017.07.025", "28756014"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "26"}, {"Year": "2022", "Month": "8", "Day": "14"}, {"Year": "2022", "Month": "8", "Day": "15"}, {"Year": "2022", "Month": "8", "Day": "26", "Hour": "1", "Minute": "40"}, {"Year": "2022", "Month": "8", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["36014874", "PMC9415189", "10.3390/nu14163367", "nu14163367"]}}], "PubmedBookArticle": []}